subscribeSubscribe
price-trendAsk Us
Paratek Announces License Grant to Almirall SEYSARA® for Greater China Region

Paratek Announces License Grant to Almirall SEYSARA® for Greater China Region
GLOBENEWSWIRE
24 Feb 2020
Share Share
Almirall LLC Announces Long-Term Safety Data For The Use Of Seysara

Almirall LLC Announces Long-Term Safety Data For The Use Of Seysara
PR NEWSWIRE
06 Dec 2019
Share Share
Why Barnes & Noble, Paratek Pharmaceuticals, and Hortonworks Jumped Today

Why Barnes & Noble, Paratek Pharmaceuticals, and Hortonworks Jumped Today
Dan Caplinger
04 Oct 2018
Share Share
Paratek enters commercial stage with 2 FDA antibiotics nods

Paratek enters commercial stage with 2 FDA antibiotics nods
Angus Liu FIERCE PHARMA
03 Oct 2018
Share Share
Green light for acne drug Seysara in the US

Green light for acne drug Seysara in the US
Selina McKee PHARMA TIMES
03 Oct 2018
Share Share
FDA Approves SEYSARA (Sarecycline) for Inflammatory Lesions of Acne Vulgaris

FDA Approves SEYSARA (Sarecycline) for Inflammatory Lesions of Acne Vulgaris
01 Oct 2018
Share Share
Almirall acquires Allergan U.S. medical dermatology portfolio

Almirall acquires Allergan U.S. medical dermatology portfolio
PR NEWSWIRE
21 Sep 2018
Share Share
Almirall acquires Allergan`s US dermatology portfolio for $650 million

Almirall acquires Allergan`s US dermatology portfolio for $650 million
G Underwood PHARMA TIMES
03 Aug 2018
Share Share
Paratek Announces FDA Advisory Committee Date for Omadacycline

Paratek Announces FDA Advisory Committee Date for Omadacycline
PRESS RELEASE
20 Jun 2018
Share Share
Paratek Provides Update on Pipeline Progress

Paratek Provides Update on Pipeline Progress
PRESS RELEASE
03 Jan 2018
Share Share